The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...

New Jersey-based pharmaceutical giant Merck is investing $1 billion in what company executives described as a continued ...

Merck, the Pharma giant with operations in Lansdale, announced on Tuesday that it will build a $1 billion “biologics center ...

We recently compiled a list of the 10 Most Profitable Cheap Stocks to Buy Now. In this article, we are going to take a look ...

Merck is injecting $1 billion into a new facility in Wilmington, Delaware to amp up U.S. drug production, especially for its ...

While updated study results confirmed the drug lowers a target protein, the therapy's effect on clinical outcomes was less ...

Dawn Health, a global leader in digital health, has secured a funding round of €11.5 million from its existing investors: Chr. Augustinus Fabrikker ...

Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection), has been granted marketing ...

Bristol Myers Squibb will spend $40 billion in the US over the next five years, CEO Christopher Boerner wrote in an opinion ...

FRANKFURT (Reuters) -Commerzbank employee representatives are calling on staff to protest against a possible takeover by the ...

CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA.